APP基因缺失apxⅢC~-/Amp~（r+）重组转移载体pBSL-Amp-R的构建
|
摘要
猪传染性胸膜肺炎(PCP)是由胸膜肺炎放线杆菌(APP)引起的高度接触性呼吸道疾病,每年给我国的畜牧产业带来巨大的经济损失。本试验设计用APP血清3型菌S1421株为材料,用氨苄青霉素抗性基因替换其毒力蛋白的激活基因ApxⅢC,对猪传染性胸膜肺炎放线杆菌ApxⅢC基因缺失重组转移载体的构建进行了研究,内容如下:
1、APP基因缺失apxⅢC~-/Amp~(r+)重组转移载体的左、右同源臂及氨苄抗性基因的克隆与鉴定
根据NCBI发表的APP血清3型的全基因组序列,参照ApxⅢC上游和下游的部分基因,分别设计引物扩增1553 bp和1537 bp的序列作为重组转移载体的左右同源臂。将左同源臂(包含部分C基因)PCR扩增后直接TA克隆到pBS-TⅡ上;筛选获得的正向克隆命名为pBSLⅡ。将右同源臂TA克隆到pMP-19 simple载体上,命名为pMD-Ra。左、右同源臂经测序后与NCBI上公布的序列同源性均达到了99.99%。
根据pMD-19 simple载体的全基因序列,设计了一对引物扩增氨苄抗性基因,大小为861 bp。将其TA克隆到pMD-19 simple载体上,鉴定正确后命名为pMD-Amp。用HindⅢ和XbaⅠ分别双酶切卡那抗性的pVAX1质粒载体和pBSL-Amp,前者回收大片段后者回收小片段,将此二片段定向连接后转化入大肠杆菌中,复壮后涂布于含有氨苄青霉素和卡那霉素的LB/X-gal平板中,挑选白斑抽取质粒进行酶切鉴定。HindⅢ和XbaⅠ双酶切后得到一条3000 bp和近2400 bp的条带。用引物Amp(U)和Amp(L)扩增氨苄抗性基因,得到一条近900 bp的条带,与预期结果相符。证明氨苄抗性基因可用ApxⅢC基因的启动子启动表达。氨苄抗性基因经测序与宝生物公布的序列同源性达到了99.9%。
2、APP基因缺失apxⅢC~-/Amp~(r+)重组转移载体的构建
用BamHⅠ和XbaⅠ双酶切pBSLⅡ和pMD-Amp,分别胶回收大片段和小片段;连接后得到中间载体pBSL-Amp。用XbaⅠ和SacⅡ双酶切载体pBSL-Amp和pMD-Ra,分别回收大片段和小片段;连接后得到重组转移载体pBSL-Amp-R。载体经酶切和PCR鉴定正确。
Porcine contagious pleuropneumonia(PCP) induced by Actinobacillus pleuropneumoniae(APP),which is a highly contagious and often fatal disease of swine.It is currently considered to be one of the most economically important diseases of swine in our country.In this research,we got Actinobacillus pleuropneumoniae serovar 3 strain S1421 as material,the apxⅢC gene of the bacterium would be replaced by ampicillin resistance gene so that ApxⅢcould not be activated.In this research,we constructed a gene deleted vector of Actinobacillus Pleuropneumoniae as pBSL-Amp-R.The paper as follows.
1,Clone and identification of left,right homologization brach and ampieillin resistance gene of APP gene deleted vector pBSL-Amp-R
By the complete genome sequence of APP serovar 3,two pairs of primers were designed and synthesized of apxⅢoperon in Actinobacillus pleuropneumoniae serovar3(APP-3) to amplify 1,553 bp in the 5' region of apxⅢC gene as left homologization brach and 1,537 bp in the 3' region of apxⅢC gene as right homologization brach.Left homologization brach was cloned into pBS-TⅡto generate plasmid in which the norientation plasmid was called pBSLⅡ.Right homologization brach was cloned into pMD19-T Simple to generate plasmid pMD19-RA.The homology of left and right homologization brach got 99.99%aligned by the sequence announced by NCBI.
One pair of primers was designed and synthesized on published sequence of pMD-19-Simple vector to amplify ampicillin resistance gene.Ampicillin resistance gene was cloned into pMD19-T-Simple to generate plasmid pMD19-Amp.The vector pVAX1 which got the Kan resistance and the vector pBSL-Amp were digested by HindⅢand XbaⅠ,and generate a plasmid.Transforme the plasmid into the E.coli to identify.We found it got the ampicillin resistance.Pick up the white bot colony and drew the plasmid,digested by HindⅢand XbaⅠ,we got two fragment as 3000bp and 2400bp,the plasmid was PCR amplification by the primer of amp(u) and amp(l),we got the fragment nearly 900bp.The ampicillin resistance gene would promoted by the operon of ApxⅢC.The homology of ampicillin resistance gene got 99.9%aligned by the sequence announced.
2,Construction of the Gene DeLeted ApxⅢC~-/Amp~(r+) Vector of Actinobacillus Pleuropneumoniae
The ampicillin resistance gene generated from digestion of pMD 19-Amp with BamHⅠand XbaⅠwas cloned into pBSLⅡbetween enzyme sites of BamHⅠand XbaⅠto generate interim plamid pBSL-Amp.Right homologization brach generated from digestion of pMD 19-R with XbaⅠand SacⅡwas cloned into pBSL-Amp between enzyme sites of XbaⅠand SacⅡto generate recombinant transfer plamid pBSL-Amp-RA.Enzyme digestion indicated the vector pBSL-Amp-RA was successfully constructed.
1、APP基因缺失apxⅢC~-/Amp~(r+)重组转移载体的左、右同源臂及氨苄抗性基因的克隆与鉴定
根据NCBI发表的APP血清3型的全基因组序列,参照ApxⅢC上游和下游的部分基因,分别设计引物扩增1553 bp和1537 bp的序列作为重组转移载体的左右同源臂。将左同源臂(包含部分C基因)PCR扩增后直接TA克隆到pBS-TⅡ上;筛选获得的正向克隆命名为pBSLⅡ。将右同源臂TA克隆到pMP-19 simple载体上,命名为pMD-Ra。左、右同源臂经测序后与NCBI上公布的序列同源性均达到了99.99%。
根据pMD-19 simple载体的全基因序列,设计了一对引物扩增氨苄抗性基因,大小为861 bp。将其TA克隆到pMD-19 simple载体上,鉴定正确后命名为pMD-Amp。用HindⅢ和XbaⅠ分别双酶切卡那抗性的pVAX1质粒载体和pBSL-Amp,前者回收大片段后者回收小片段,将此二片段定向连接后转化入大肠杆菌中,复壮后涂布于含有氨苄青霉素和卡那霉素的LB/X-gal平板中,挑选白斑抽取质粒进行酶切鉴定。HindⅢ和XbaⅠ双酶切后得到一条3000 bp和近2400 bp的条带。用引物Amp(U)和Amp(L)扩增氨苄抗性基因,得到一条近900 bp的条带,与预期结果相符。证明氨苄抗性基因可用ApxⅢC基因的启动子启动表达。氨苄抗性基因经测序与宝生物公布的序列同源性达到了99.9%。
2、APP基因缺失apxⅢC~-/Amp~(r+)重组转移载体的构建
用BamHⅠ和XbaⅠ双酶切pBSLⅡ和pMD-Amp,分别胶回收大片段和小片段;连接后得到中间载体pBSL-Amp。用XbaⅠ和SacⅡ双酶切载体pBSL-Amp和pMD-Ra,分别回收大片段和小片段;连接后得到重组转移载体pBSL-Amp-R。载体经酶切和PCR鉴定正确。
Porcine contagious pleuropneumonia(PCP) induced by Actinobacillus pleuropneumoniae(APP),which is a highly contagious and often fatal disease of swine.It is currently considered to be one of the most economically important diseases of swine in our country.In this research,we got Actinobacillus pleuropneumoniae serovar 3 strain S1421 as material,the apxⅢC gene of the bacterium would be replaced by ampicillin resistance gene so that ApxⅢcould not be activated.In this research,we constructed a gene deleted vector of Actinobacillus Pleuropneumoniae as pBSL-Amp-R.The paper as follows.
1,Clone and identification of left,right homologization brach and ampieillin resistance gene of APP gene deleted vector pBSL-Amp-R
By the complete genome sequence of APP serovar 3,two pairs of primers were designed and synthesized of apxⅢoperon in Actinobacillus pleuropneumoniae serovar3(APP-3) to amplify 1,553 bp in the 5' region of apxⅢC gene as left homologization brach and 1,537 bp in the 3' region of apxⅢC gene as right homologization brach.Left homologization brach was cloned into pBS-TⅡto generate plasmid in which the norientation plasmid was called pBSLⅡ.Right homologization brach was cloned into pMD19-T Simple to generate plasmid pMD19-RA.The homology of left and right homologization brach got 99.99%aligned by the sequence announced by NCBI.
One pair of primers was designed and synthesized on published sequence of pMD-19-Simple vector to amplify ampicillin resistance gene.Ampicillin resistance gene was cloned into pMD19-T-Simple to generate plasmid pMD19-Amp.The vector pVAX1 which got the Kan resistance and the vector pBSL-Amp were digested by HindⅢand XbaⅠ,and generate a plasmid.Transforme the plasmid into the E.coli to identify.We found it got the ampicillin resistance.Pick up the white bot colony and drew the plasmid,digested by HindⅢand XbaⅠ,we got two fragment as 3000bp and 2400bp,the plasmid was PCR amplification by the primer of amp(u) and amp(l),we got the fragment nearly 900bp.The ampicillin resistance gene would promoted by the operon of ApxⅢC.The homology of ampicillin resistance gene got 99.9%aligned by the sequence announced.
2,Construction of the Gene DeLeted ApxⅢC~-/Amp~(r+) Vector of Actinobacillus Pleuropneumoniae
The ampicillin resistance gene generated from digestion of pMD 19-Amp with BamHⅠand XbaⅠwas cloned into pBSLⅡbetween enzyme sites of BamHⅠand XbaⅠto generate interim plamid pBSL-Amp.Right homologization brach generated from digestion of pMD 19-R with XbaⅠand SacⅡwas cloned into pBSL-Amp between enzyme sites of XbaⅠand SacⅡto generate recombinant transfer plamid pBSL-Amp-RA.Enzyme digestion indicated the vector pBSL-Amp-RA was successfully constructed.
引文
[1]Pattison,I.H.,D.G.Howell,J.Elliot.A haemophilus-like organism isolated from pig lung and the associated pneumonic lesions[J].J Comp Pathol,1957,67(4):320-30
[2]陈小玲,杨旭夫.猪传染性胸膜肺炎的流行现状和防制措施[J].中国兽医杂志,2001,37(7):33-5.
[3]Gram,T.An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes—evaluation of isolates from lungs and tonsils of pigs[J].Vet Microbiol,2000,75(1):43-57.
[4]Mulks MH,Buysse JM.A targeted mutagenesis system for Actinobacillus pleuropneumoniae]J].Gene,1995,165(1):61-6.
[5]Maas,A.,et al.Development ofa DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection[J].Vaccine,2006,24(49-50):7226-37.
[6]陈小玲,杨旭夫.猪传染性胸膜肺炎的流行现状和防制措施[J].中国兽医杂志,2001,37(7):33-5.
[7]蔡宝祥.猪传染性胸膜肺炎的诊断与防治[J].辽宁畜牧兽医,1996,(3):41-2.
[8]徐晓娟,何启盖,陈焕春,等.猪传染性胸膜肺炎的诊断和疫苗研究进展[J].中国预防兽医学报,2003,25(4):315-317.
[9]张彦明,张耀相.胸膜肺炎放线杆菌的分离鉴定及免疫预防[J].中国兽医科技,2002,32(5):21-2.
[10]吴硕显.胸膜肺炎放线杆菌血清型的地理分布[J].中国兽医杂志,1995,21(1):13-4.
[11]Fenwiek B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[12]Frey,J.,et al.,Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[13]Kuhnert,P.,et al.,Detection of RTX toxin genes in gram-negative bacteria with a set of specific probes[J].APP1 Environ Microbiol,1997,63(6):2258-65.
[14]Kamp,E.M.,et al.,Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies[J].Infect Immun,1991,59(9):3079-85.
[15]谢宝东,何后军,祝仁发,等.胸膜肺炎放线杆菌毒力因子研究进展[J].动物医学进展,2005,26(5):10-12.
[16]Schaller,A.,R.Kuhn,et al."Characterization of apxIVA,a new RTX determinant of Actinobacillus pleuropneumoniae."[J]Microbiology,1999,145(Pt 8):2105-16.
[17]Schaller,A.,et al.,Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA[J].Vet Microbiol,2001,79(1):47-62.
[18]Frey,J.,et al.,Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[19]王春来,杨旭夫.胸膜肺炎放线杆菌主要毒力因子的致病性及其免疫原性研究进展[J].预防兽医学进展,2001,3(1):10-2.
[20]胡成名,文心田,曹三杰,等.猪胸膜肺炎放线杆菌Apx毒素的分子生物学与致病机理[J].动物医学进展,2007,7(1):94-98.
[21]Fenwick B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[22]Lombin,L.H.,S.Rosendal,et al."Evaluation of the complement fixation test for the diagnosis of pleuropneumonia of swine caused by Haemophilus pleuropneumoniae."[J]Can J Comp Med,1982,46(2):109-14.
[23]Nielsen R.Haemophilus pleuropneumoniae serotypes—cross protection experiments[J].Nord Vet Med,1984,36(7-8):221-34.
[24]李开玉,朱士盛,杜华宏,等.用琼扩法测定胸膜肺炎嗜血杆菌的血清型[J].中国兽医科技,1991,1(1):37-39.
[25]逯忠新,鲁炳义,赵萍,等.用间接血凝试验检测猪传染性胸膜肺炎[J].中国兽医科技,1999,29(10):25-27.
[26]Rosendal,S.,L.Lombin,et al."Serotyping and detection of Haemophilus pleuropneumoniae by indirect fluorescent antibody technique."[J]Can J Comp Med,1981,45(3):271-4.
[27]Inzana,T.J."Simplified procedure for preparation of sensitized latex particles to detect capsular polysaccharides:APPlication to typing and diagnosis of Actinobacillus pleuropneumoniae."[J]J Clin Microbiol,1995,33(9):2297-303.
[28]Gunnarsson,A."Serologic studies on porcine strains of Haemophilus parahaemolyticus (pleuropneumoniae):extraction of type-specific antigens."[J]Am J Vet Res,1979,40(4):469-72.
[29]Trottier,Y.L.,P.F.Wright,et al.."Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5."[J]J Clin Microbiol,1992,30(1):46-53.
[30]Nielsen,R."Detection of antibodies against Actinobacillus pleuropneumoniae,serotype 2 in porcine colostrum using a blocking enzyme-linked immunosorbent assay specific for serotype 2."[J]Vet Microbiol,1995,43(4):277-81.
[31]Nielsen,R.,J.F.van den Bosch,et al."Evaluation of an indirect enzyme-linked immunosorbent assay(ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae."[J]Vet Microbiol,2000,71(1-2):81-7.
[32]Leiner,G.,B.Franz,et al."A novel enzyme-linked immunosorbent assay using the recombinant Actinobacillus pleuropneumoniae ApxⅡ antigen for diagnosis of pleuropneumonia in pig herds."[J]Clin Diagn Lab Immunol,1999,6(4):630-2.
[33]Grondahl-Hansen,J.,K.Barfod,et al."Development and evaluation of a mixed long-chain lipopolysaccharide based ELISA for serological surveillance of infection with Actinobacillus pleuropneumoniae serotypes 2,6 and 12 in pig herds."[J].Vet Microbiol,2003,96(1):41-51.
[34]刘军发,陈焕春,熊远著,等.胸膜肺炎放线杆菌PCR定向突变系统的初步建立及胸膜肺炎放线杆菌OmlA-ELISA检测方法的建立[D].武汉:华中农业大学,2005:28-32.
[35]Gram,T.,P.Ahrens,et al."An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes—evaluation of isolates from lungs and tonsils of pigs."[J]Vet Microbiol,2000,75(1):43-57.
[36]Hernanz Moral,C.,A.Cascon Soriano,et al."Molecular cloning and sequencing of the aroA gene from Actinobacillus pleuropneumoniae and its use in a PCR assay for rapid identification."[J]J Clin Microbiol,1999,37(5):1575-8.
[37]Chiers,K.,I.Van Overbeke,et al."Detection of Actinobacillus pleuropneumoniae in cultures from nasal and tonsillar swabs of pigs by a PCR assay based on the nucleotide sequence of a dsbE-like gene."[J]Vet Microbiol,2001,83(2):147-59.
[38]Victor A.de la Puente-Redondoa,Noemi Garcia del Blancoa,Cesar B.Gutierrez-Martina,Detection and subtyping of Actinobacillus pleuropneumoniae strainsby PCR-RFLP analysis of the tbpA and tbpB genes[J].Research in Microbiology,1999,58(2-4):239-49.
[39]杨旭夫译.猪胸膜肺炎放线杆菌(嗜血杆菌)感染症的防制[J].国外医学一畜禽传染病,1989,9(2):45-46.
[40]Haesebrouck F,Chiers K,Van Overbeke I,et al.Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection[J]. Vet Microbiol, 1997,58(2-4): 239-49.
[41] Nielsen R. Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae). Serotypes 8, 3 and 6. Serological response and cross immunity in pigs[J]. Nord Vet Med, 1985,37(4): 217-27.
[42] Jolie RA, Mulks MH, Thacker BJ. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B[J]. Vet Microbiol, 1995,45(4): 383-91.
[43] Fuller TE, Thacker BJ, Duran CO, et al. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine[J]. Vaccine, 2000,18(25): 2867-77.
[44] Rosendal S, MacInnes JI. Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1[J]. Am J Vet Res, 1990,51(5): 711-7.
[45] Inzana TJ, Todd J, Veit HP. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines[J]. Infect Immun, 1993,61(5): 1682-6.
[46] Devenish J, Rosendal S, Bosse JT, et al. Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds[J]. J Clin Microbiol, 1990,28(4): 789-91.
[47] Tadjine, M. and K. R. Mittal. "Study of antigenic heterogeneity among Actinobacillus pleuropneumoniae serotype 7 strains." [J]Vet Microbiol, 2001,78(1): 49-60.
[48] Byrd W, Kadis S. Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants[J]. Infect Immun, 1992,60(8): 3042-51.
[49] Beaudet R, McSween G, Boulay G, et al. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination[J]. Vet Microbiol, 1994,39(1-2): 71-81.
[50] Stine DL, Fedorka-Cray PJ, Huether MJ, et al. Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1 [J]. Am J Vet Res, 1994,55(9): 1238-43.
[51] Oishi, E., T. Kitajima, et al. "Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1,2 and 5 in pigs"[J].Vet Med Sci, 1995,57(6): 1356-60
[52] Seah JN, Frey J, Kwang J. The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice[J]. Infect Immun, 2002,70(11): 6464-7.
[53] Bhatia, B., K. R. Mittal, et al. "Factors involved in immunity against Actinobacillus pleuropneumoniae in mice." [J]. Vet Microbiol, 1991,29(2): 147-58.
[54] Goethe, R., O. F. Gonzales, et al. "A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction." [J]. Vaccine, 2000,19(7-8): 966-75.
[55] Fuller, T. E., B. J. Thacker, et al. "A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine."[J]. Infect Immun, 1996,64(11): 4659-64
[56] Prideaux, C. T, L. Pierce, et al. "Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination."[J]. Curr Microbiol, 1998,37(5): 324-32.
[57] Prideaux, C. T, C. Lenghaus, et al. "Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon." Infect Immun,v,67(4): 1962-6.
[58] Ingham, A., Y. Zhang, et al. "Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ." [J].Vet Microbiol, 2002,84(3): 263-73.
[59]Tonpitak,W.,N.Baltes,et al."Construction of an Actinobacillus pleuropneumoniae serotype 2prototype live negative-marker vaccine."[J].Infect Immun,2002,70(12):7120-5.
[60]贝为成.猪胸膜肺炎放线杆菌apxⅡ基因工程突变株构建及其生物学特性研究[D].武汉:华中农业大学,2005:3540.
[61]Hensel,A.,L.A.van Leengoed,et al."Induction of protective immunity by aerosol or oral APPlication of candidate vaccines in a dose-controlled pig aerosol infection model."[J].J Biotechnol,1996,44(1-3):171-81.
[62]Hensel A,Huter V,Katinger A,et al.Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state[J].Vaccine,2000,18(26):2945-55.
[63]Inzana,T.J.,J.Todd,et al."Safety,stability,and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines."[J].Infect Immun,1993,61(5):1682-6.
[64]丛延广,胡福泉.利用转座子建立细菌单基因突变株库的策略和方法[J],微生物学免疫学进展,2008(2):78-80
[65]Rioux S,Galameau C,Harel J,et al.Isolation and characterization of mini-Tn10lipopolysaccharide mutants of Actinobacillus pleuropneumoniae serotype 1[J].Can J Microbiol,1999,45(12):1017-26.
[66]Mulks MH,Buysse JM.A targeted mutagenesis system for Actinobacillus pleuropneumoniae[J].Gene,1995,165(1):61-6.
[67]Jansen R,Briaire J,Kamp EM,et al.The CAMP effect of Actinobacillus pleuropneumoniae is caused by Apx toxins[J].FEMS Microbiol Lett,1995,126(2):139-43.
[68]Prideaux,D.J.and V.R.Marshall."A "common" surgery curriculum:health care delivery and undergraduate surgical education in Australian teaching hospitals."[J].World J Surg,1994,18(5):657-61;discussion 656.
[69]Fuller TE,Thacker BJ,Mulks MH.A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine[J].Infect Immun,1996,64(11):4659-64.
[70]Byrd W,Hooke AM.Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice[J].Infect Immun,1997,65(6):2206-10.
[71]Ward,C.K.,M.L.Lawrence,et al."Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a:concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A.pleuropneumoniae serotype 1."[J].Infect Immun,1998,66(7):3326-36.
[72]Oswald,W.,W.Tonpitak,et al.."A single-step transconjugation system for the introduction of unmarked deletions into Actinobacillus pleuropneumoniae serotype 7 using a sucrose sensitivity marker."[J].FEMS Microbiol Lett,1999,179(1):153-60.
[73]Fuller,T.E.,B.J.Thacker,et al."A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine."[J].Vaccine,2000,18(25):2867-77.
[74]Sheehan,B.J.,P.R.Langford,et al."[Cu,Zn]-Superoxide dismutase mutants of the swine pathogen Actinobacillus pleuropneumoniae are unattenuated in infections of the natural host."[J].Infect Immun,2000,68(8):4778-8
[75]林荔雯.胸膜肺炎放线杆菌ΔapxⅠC/ΔapxⅡC双基因缺失株的构建及其生物学特性和免疫原性的研究[D].武汉:华中农业大学,2007:28-32.
[76]逯忠新,赵萍,邵英德,等.猪传染性胸膜肺炎三价灭活疫苗的研究——菌种选择、疫苗制备及安全性试验[J].中国兽医科技,2002,(03):32-34
[77]Tonpitak W,Baltes N,Hennig-Pauka I,et al.Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine[J].Infect Immun,2002,70(12):7120-5.
[78]Bei,W.,Q.He,et al."Construction and characterization of a live,attenuated apxⅡCA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker."[J].FEMS Microbiol Lett,2005,243(1):21-7.
[79]Shin SJ,Bae JL,Cho YW,et al.Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxⅡA[J].FEMS Immunol Med Microbiol,2005,43(2):155-64.
[80]Sebunya TN,Saunders JR.Haemophilus pleuropneumoniae infection in swine:a review[J].J Am Vet Med Assoc,1983,182(12):1331-7.
[81]Fenwick B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[82]Blackall PJ,Klaasen HL,van den Bosch H,et al.Proposal of a new serovar of Actinobacillus pleuropneumoniae:serovar 15[J].Vet Microbiol,2002,84(1-2):47-52.
[83]Kamp EM,Popma JK,Anakotta J,et al.Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies[J].Infect Immun,1991,59(9):3079-85.
[84]Frey J.Virulence in Actinobacillus pleuropneumoniae and RTX toxins[J].Trends Microbiol,1995,3(7):257-61.
[85]Schaller A,Kuhn R,Kuhnert P,et al.Characterization of apxIVA,a new RTX determinant of Actinobacillus pleuropneumoniae[J].Microbiology,1999,145(Pt 8):2105-16.
[86]Boekema,B.K.,E.M.Kamp,et al.,Both ApxⅠ and ApxⅡ of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence[J].Vet Microbiol,2004,100(1-2):17-23
[87]Frey J,Bosse JT,Chang YF,et al.Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[88]Inzana TJ,Todd J,Ma JN,et al.Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5:role of the 110 kilodalton hemolysin in virulence and immunoprotection[J].Microb Pathog,1991,10(4):281-96.
[89]Forestier,C.and R.A.Welch."Identification of RTX toxin target cell specificity domains by use of hybrid genes."[J].Infect Immun,1991,59(11):4212-20.
[90]Frey,J."Construction of a broad host range shuttle vector for gene cloning and expression in Actinobacillus pleuropneumoniae and other Pasteurellaceae."[J].Res Microbiol,1992,143(3):263-9.
[91]陈汉阳,刘军发,何启盖,等.猪胸膜肺炎放线杆菌毒素ⅢA基因的克隆序列分析及原核表达[J].微生物学报,2003,43(3):324-329.
[92]Nielsen R.Haemophilus pleuropneumoniae serotypes—cross protection experiments[J].Nord Vet Med,1984,36(7):221-34.
[93]Tonpitak,W.,S.Thiede,et al."Actinobacillus pleuropneumoniae iron transport:a set of exbBD genes is transcriptionally linked to the tbpB gene and required for utilization of transferrin-bound iron."[J].Infect Immun,2000,68(3):1164-70.
[94]刘杰,杨旭夫,王春来.胸膜肺炎放线杆菌溶血毒素特性鉴定及免疫原性研究[J]中国预防兽医学报,2001,23(3):23-25
[95]Thomas,K.R.and M.R.Capecchi."Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells."[J].Cell,1987,51(3):503-12.
[96]Hasty,P.,J.Rivera-Perez,et al."The length of homology required for gene targeting in embryonic stem cells."[J].Mol Cell Biol,1991,11(11):5586-91.
[97]Myeong S.Lee,Chaok Seok,and Donald A.Mossison.Insertion-Duplication Mutagenesis in Streptococcus pneumoniae:Targeting Fragment Length is a Critical Parameter in use as a random insertion tool[J].APPlied and Environmental Microbiology,1998,1(1):4796-4802.
[98]Lalonde,G.,J.F.Miller,et al."Transformation of Actinobacillus pleuropneumoniae and analysis of R factors by electroporation."[J].Am J Vet Res,1989,50(11):1957-60.
[99]Jansen,R.,J.Briaire,et al."Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils."[J].Infect Immun,1995,63(1):27-37.
[100]Knutson,J.C.and D.Yee."Electroporation:parameters affecting transfer of DNA into mammalian cells."[J].Anal Biochem,1987,164(1):44-52.
[101]Bullas,L.R.and J.I.Ryu."Salmonella typhimurium LT2 strains which are r-m+ for all three chromosomally located systems of DNA restriction and modification."[J].J Bacteriol,1983,156(1):471-4.
[102]Raleigh,E.A.,J.Benner,et al.."Nomenclature relating to restriction of modified DNA in Escherichia coli."[J].J Bacteriol,1991,173(8):2707-9.
[103]王恒梁,冯尔玲,史兆兴,等.Red系统快速敲除痢疾杆菌asd基因[J].军事医学科学院刊,2002,26(3):161-164
[104]Datsenko K A,Wanner B L.One step inactivation of chromosomal genes in Escherichia coli K12 using PCR products[J].Proc Natl Acad Sci USA,2000,97(1):6640-6645
[105]Mulks,M.H.and J.M.Buysse."A targeted mutagenesis system for Actinobacillus pleuropneumoniae."[J].Gene,1995,165(1):61-6.
[2]陈小玲,杨旭夫.猪传染性胸膜肺炎的流行现状和防制措施[J].中国兽医杂志,2001,37(7):33-5.
[3]Gram,T.An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes—evaluation of isolates from lungs and tonsils of pigs[J].Vet Microbiol,2000,75(1):43-57.
[4]Mulks MH,Buysse JM.A targeted mutagenesis system for Actinobacillus pleuropneumoniae]J].Gene,1995,165(1):61-6.
[5]Maas,A.,et al.Development ofa DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection[J].Vaccine,2006,24(49-50):7226-37.
[6]陈小玲,杨旭夫.猪传染性胸膜肺炎的流行现状和防制措施[J].中国兽医杂志,2001,37(7):33-5.
[7]蔡宝祥.猪传染性胸膜肺炎的诊断与防治[J].辽宁畜牧兽医,1996,(3):41-2.
[8]徐晓娟,何启盖,陈焕春,等.猪传染性胸膜肺炎的诊断和疫苗研究进展[J].中国预防兽医学报,2003,25(4):315-317.
[9]张彦明,张耀相.胸膜肺炎放线杆菌的分离鉴定及免疫预防[J].中国兽医科技,2002,32(5):21-2.
[10]吴硕显.胸膜肺炎放线杆菌血清型的地理分布[J].中国兽医杂志,1995,21(1):13-4.
[11]Fenwiek B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[12]Frey,J.,et al.,Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[13]Kuhnert,P.,et al.,Detection of RTX toxin genes in gram-negative bacteria with a set of specific probes[J].APP1 Environ Microbiol,1997,63(6):2258-65.
[14]Kamp,E.M.,et al.,Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies[J].Infect Immun,1991,59(9):3079-85.
[15]谢宝东,何后军,祝仁发,等.胸膜肺炎放线杆菌毒力因子研究进展[J].动物医学进展,2005,26(5):10-12.
[16]Schaller,A.,R.Kuhn,et al."Characterization of apxIVA,a new RTX determinant of Actinobacillus pleuropneumoniae."[J]Microbiology,1999,145(Pt 8):2105-16.
[17]Schaller,A.,et al.,Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA[J].Vet Microbiol,2001,79(1):47-62.
[18]Frey,J.,et al.,Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[19]王春来,杨旭夫.胸膜肺炎放线杆菌主要毒力因子的致病性及其免疫原性研究进展[J].预防兽医学进展,2001,3(1):10-2.
[20]胡成名,文心田,曹三杰,等.猪胸膜肺炎放线杆菌Apx毒素的分子生物学与致病机理[J].动物医学进展,2007,7(1):94-98.
[21]Fenwick B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[22]Lombin,L.H.,S.Rosendal,et al."Evaluation of the complement fixation test for the diagnosis of pleuropneumonia of swine caused by Haemophilus pleuropneumoniae."[J]Can J Comp Med,1982,46(2):109-14.
[23]Nielsen R.Haemophilus pleuropneumoniae serotypes—cross protection experiments[J].Nord Vet Med,1984,36(7-8):221-34.
[24]李开玉,朱士盛,杜华宏,等.用琼扩法测定胸膜肺炎嗜血杆菌的血清型[J].中国兽医科技,1991,1(1):37-39.
[25]逯忠新,鲁炳义,赵萍,等.用间接血凝试验检测猪传染性胸膜肺炎[J].中国兽医科技,1999,29(10):25-27.
[26]Rosendal,S.,L.Lombin,et al."Serotyping and detection of Haemophilus pleuropneumoniae by indirect fluorescent antibody technique."[J]Can J Comp Med,1981,45(3):271-4.
[27]Inzana,T.J."Simplified procedure for preparation of sensitized latex particles to detect capsular polysaccharides:APPlication to typing and diagnosis of Actinobacillus pleuropneumoniae."[J]J Clin Microbiol,1995,33(9):2297-303.
[28]Gunnarsson,A."Serologic studies on porcine strains of Haemophilus parahaemolyticus (pleuropneumoniae):extraction of type-specific antigens."[J]Am J Vet Res,1979,40(4):469-72.
[29]Trottier,Y.L.,P.F.Wright,et al.."Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5."[J]J Clin Microbiol,1992,30(1):46-53.
[30]Nielsen,R."Detection of antibodies against Actinobacillus pleuropneumoniae,serotype 2 in porcine colostrum using a blocking enzyme-linked immunosorbent assay specific for serotype 2."[J]Vet Microbiol,1995,43(4):277-81.
[31]Nielsen,R.,J.F.van den Bosch,et al."Evaluation of an indirect enzyme-linked immunosorbent assay(ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae."[J]Vet Microbiol,2000,71(1-2):81-7.
[32]Leiner,G.,B.Franz,et al."A novel enzyme-linked immunosorbent assay using the recombinant Actinobacillus pleuropneumoniae ApxⅡ antigen for diagnosis of pleuropneumonia in pig herds."[J]Clin Diagn Lab Immunol,1999,6(4):630-2.
[33]Grondahl-Hansen,J.,K.Barfod,et al."Development and evaluation of a mixed long-chain lipopolysaccharide based ELISA for serological surveillance of infection with Actinobacillus pleuropneumoniae serotypes 2,6 and 12 in pig herds."[J].Vet Microbiol,2003,96(1):41-51.
[34]刘军发,陈焕春,熊远著,等.胸膜肺炎放线杆菌PCR定向突变系统的初步建立及胸膜肺炎放线杆菌OmlA-ELISA检测方法的建立[D].武汉:华中农业大学,2005:28-32.
[35]Gram,T.,P.Ahrens,et al."An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes—evaluation of isolates from lungs and tonsils of pigs."[J]Vet Microbiol,2000,75(1):43-57.
[36]Hernanz Moral,C.,A.Cascon Soriano,et al."Molecular cloning and sequencing of the aroA gene from Actinobacillus pleuropneumoniae and its use in a PCR assay for rapid identification."[J]J Clin Microbiol,1999,37(5):1575-8.
[37]Chiers,K.,I.Van Overbeke,et al."Detection of Actinobacillus pleuropneumoniae in cultures from nasal and tonsillar swabs of pigs by a PCR assay based on the nucleotide sequence of a dsbE-like gene."[J]Vet Microbiol,2001,83(2):147-59.
[38]Victor A.de la Puente-Redondoa,Noemi Garcia del Blancoa,Cesar B.Gutierrez-Martina,Detection and subtyping of Actinobacillus pleuropneumoniae strainsby PCR-RFLP analysis of the tbpA and tbpB genes[J].Research in Microbiology,1999,58(2-4):239-49.
[39]杨旭夫译.猪胸膜肺炎放线杆菌(嗜血杆菌)感染症的防制[J].国外医学一畜禽传染病,1989,9(2):45-46.
[40]Haesebrouck F,Chiers K,Van Overbeke I,et al.Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection[J]. Vet Microbiol, 1997,58(2-4): 239-49.
[41] Nielsen R. Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae). Serotypes 8, 3 and 6. Serological response and cross immunity in pigs[J]. Nord Vet Med, 1985,37(4): 217-27.
[42] Jolie RA, Mulks MH, Thacker BJ. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B[J]. Vet Microbiol, 1995,45(4): 383-91.
[43] Fuller TE, Thacker BJ, Duran CO, et al. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine[J]. Vaccine, 2000,18(25): 2867-77.
[44] Rosendal S, MacInnes JI. Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1[J]. Am J Vet Res, 1990,51(5): 711-7.
[45] Inzana TJ, Todd J, Veit HP. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines[J]. Infect Immun, 1993,61(5): 1682-6.
[46] Devenish J, Rosendal S, Bosse JT, et al. Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds[J]. J Clin Microbiol, 1990,28(4): 789-91.
[47] Tadjine, M. and K. R. Mittal. "Study of antigenic heterogeneity among Actinobacillus pleuropneumoniae serotype 7 strains." [J]Vet Microbiol, 2001,78(1): 49-60.
[48] Byrd W, Kadis S. Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants[J]. Infect Immun, 1992,60(8): 3042-51.
[49] Beaudet R, McSween G, Boulay G, et al. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination[J]. Vet Microbiol, 1994,39(1-2): 71-81.
[50] Stine DL, Fedorka-Cray PJ, Huether MJ, et al. Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1 [J]. Am J Vet Res, 1994,55(9): 1238-43.
[51] Oishi, E., T. Kitajima, et al. "Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1,2 and 5 in pigs"[J].Vet Med Sci, 1995,57(6): 1356-60
[52] Seah JN, Frey J, Kwang J. The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice[J]. Infect Immun, 2002,70(11): 6464-7.
[53] Bhatia, B., K. R. Mittal, et al. "Factors involved in immunity against Actinobacillus pleuropneumoniae in mice." [J]. Vet Microbiol, 1991,29(2): 147-58.
[54] Goethe, R., O. F. Gonzales, et al. "A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction." [J]. Vaccine, 2000,19(7-8): 966-75.
[55] Fuller, T. E., B. J. Thacker, et al. "A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine."[J]. Infect Immun, 1996,64(11): 4659-64
[56] Prideaux, C. T, L. Pierce, et al. "Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination."[J]. Curr Microbiol, 1998,37(5): 324-32.
[57] Prideaux, C. T, C. Lenghaus, et al. "Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon." Infect Immun,v,67(4): 1962-6.
[58] Ingham, A., Y. Zhang, et al. "Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ." [J].Vet Microbiol, 2002,84(3): 263-73.
[59]Tonpitak,W.,N.Baltes,et al."Construction of an Actinobacillus pleuropneumoniae serotype 2prototype live negative-marker vaccine."[J].Infect Immun,2002,70(12):7120-5.
[60]贝为成.猪胸膜肺炎放线杆菌apxⅡ基因工程突变株构建及其生物学特性研究[D].武汉:华中农业大学,2005:3540.
[61]Hensel,A.,L.A.van Leengoed,et al."Induction of protective immunity by aerosol or oral APPlication of candidate vaccines in a dose-controlled pig aerosol infection model."[J].J Biotechnol,1996,44(1-3):171-81.
[62]Hensel A,Huter V,Katinger A,et al.Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state[J].Vaccine,2000,18(26):2945-55.
[63]Inzana,T.J.,J.Todd,et al."Safety,stability,and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines."[J].Infect Immun,1993,61(5):1682-6.
[64]丛延广,胡福泉.利用转座子建立细菌单基因突变株库的策略和方法[J],微生物学免疫学进展,2008(2):78-80
[65]Rioux S,Galameau C,Harel J,et al.Isolation and characterization of mini-Tn10lipopolysaccharide mutants of Actinobacillus pleuropneumoniae serotype 1[J].Can J Microbiol,1999,45(12):1017-26.
[66]Mulks MH,Buysse JM.A targeted mutagenesis system for Actinobacillus pleuropneumoniae[J].Gene,1995,165(1):61-6.
[67]Jansen R,Briaire J,Kamp EM,et al.The CAMP effect of Actinobacillus pleuropneumoniae is caused by Apx toxins[J].FEMS Microbiol Lett,1995,126(2):139-43.
[68]Prideaux,D.J.and V.R.Marshall."A "common" surgery curriculum:health care delivery and undergraduate surgical education in Australian teaching hospitals."[J].World J Surg,1994,18(5):657-61;discussion 656.
[69]Fuller TE,Thacker BJ,Mulks MH.A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine[J].Infect Immun,1996,64(11):4659-64.
[70]Byrd W,Hooke AM.Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice[J].Infect Immun,1997,65(6):2206-10.
[71]Ward,C.K.,M.L.Lawrence,et al."Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a:concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A.pleuropneumoniae serotype 1."[J].Infect Immun,1998,66(7):3326-36.
[72]Oswald,W.,W.Tonpitak,et al.."A single-step transconjugation system for the introduction of unmarked deletions into Actinobacillus pleuropneumoniae serotype 7 using a sucrose sensitivity marker."[J].FEMS Microbiol Lett,1999,179(1):153-60.
[73]Fuller,T.E.,B.J.Thacker,et al."A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine."[J].Vaccine,2000,18(25):2867-77.
[74]Sheehan,B.J.,P.R.Langford,et al."[Cu,Zn]-Superoxide dismutase mutants of the swine pathogen Actinobacillus pleuropneumoniae are unattenuated in infections of the natural host."[J].Infect Immun,2000,68(8):4778-8
[75]林荔雯.胸膜肺炎放线杆菌ΔapxⅠC/ΔapxⅡC双基因缺失株的构建及其生物学特性和免疫原性的研究[D].武汉:华中农业大学,2007:28-32.
[76]逯忠新,赵萍,邵英德,等.猪传染性胸膜肺炎三价灭活疫苗的研究——菌种选择、疫苗制备及安全性试验[J].中国兽医科技,2002,(03):32-34
[77]Tonpitak W,Baltes N,Hennig-Pauka I,et al.Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine[J].Infect Immun,2002,70(12):7120-5.
[78]Bei,W.,Q.He,et al."Construction and characterization of a live,attenuated apxⅡCA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker."[J].FEMS Microbiol Lett,2005,243(1):21-7.
[79]Shin SJ,Bae JL,Cho YW,et al.Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxⅡA[J].FEMS Immunol Med Microbiol,2005,43(2):155-64.
[80]Sebunya TN,Saunders JR.Haemophilus pleuropneumoniae infection in swine:a review[J].J Am Vet Med Assoc,1983,182(12):1331-7.
[81]Fenwick B,Henry S.Porcine pleuropneumonia[J].J Am Vet Med Assoc,1994,204(9):1334-40.
[82]Blackall PJ,Klaasen HL,van den Bosch H,et al.Proposal of a new serovar of Actinobacillus pleuropneumoniae:serovar 15[J].Vet Microbiol,2002,84(1-2):47-52.
[83]Kamp EM,Popma JK,Anakotta J,et al.Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies[J].Infect Immun,1991,59(9):3079-85.
[84]Frey J.Virulence in Actinobacillus pleuropneumoniae and RTX toxins[J].Trends Microbiol,1995,3(7):257-61.
[85]Schaller A,Kuhn R,Kuhnert P,et al.Characterization of apxIVA,a new RTX determinant of Actinobacillus pleuropneumoniae[J].Microbiology,1999,145(Pt 8):2105-16.
[86]Boekema,B.K.,E.M.Kamp,et al.,Both ApxⅠ and ApxⅡ of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence[J].Vet Microbiol,2004,100(1-2):17-23
[87]Frey J,Bosse JT,Chang YF,et al.Actinobacillus pleuropneumoniae RTX-toxins:uniform designation of haemolysins,cytolysins,pleurotoxin and their genes[J].J Gen Microbiol,1993,139(8):1723-8.
[88]Inzana TJ,Todd J,Ma JN,et al.Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5:role of the 110 kilodalton hemolysin in virulence and immunoprotection[J].Microb Pathog,1991,10(4):281-96.
[89]Forestier,C.and R.A.Welch."Identification of RTX toxin target cell specificity domains by use of hybrid genes."[J].Infect Immun,1991,59(11):4212-20.
[90]Frey,J."Construction of a broad host range shuttle vector for gene cloning and expression in Actinobacillus pleuropneumoniae and other Pasteurellaceae."[J].Res Microbiol,1992,143(3):263-9.
[91]陈汉阳,刘军发,何启盖,等.猪胸膜肺炎放线杆菌毒素ⅢA基因的克隆序列分析及原核表达[J].微生物学报,2003,43(3):324-329.
[92]Nielsen R.Haemophilus pleuropneumoniae serotypes—cross protection experiments[J].Nord Vet Med,1984,36(7):221-34.
[93]Tonpitak,W.,S.Thiede,et al."Actinobacillus pleuropneumoniae iron transport:a set of exbBD genes is transcriptionally linked to the tbpB gene and required for utilization of transferrin-bound iron."[J].Infect Immun,2000,68(3):1164-70.
[94]刘杰,杨旭夫,王春来.胸膜肺炎放线杆菌溶血毒素特性鉴定及免疫原性研究[J]中国预防兽医学报,2001,23(3):23-25
[95]Thomas,K.R.and M.R.Capecchi."Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells."[J].Cell,1987,51(3):503-12.
[96]Hasty,P.,J.Rivera-Perez,et al."The length of homology required for gene targeting in embryonic stem cells."[J].Mol Cell Biol,1991,11(11):5586-91.
[97]Myeong S.Lee,Chaok Seok,and Donald A.Mossison.Insertion-Duplication Mutagenesis in Streptococcus pneumoniae:Targeting Fragment Length is a Critical Parameter in use as a random insertion tool[J].APPlied and Environmental Microbiology,1998,1(1):4796-4802.
[98]Lalonde,G.,J.F.Miller,et al."Transformation of Actinobacillus pleuropneumoniae and analysis of R factors by electroporation."[J].Am J Vet Res,1989,50(11):1957-60.
[99]Jansen,R.,J.Briaire,et al."Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils."[J].Infect Immun,1995,63(1):27-37.
[100]Knutson,J.C.and D.Yee."Electroporation:parameters affecting transfer of DNA into mammalian cells."[J].Anal Biochem,1987,164(1):44-52.
[101]Bullas,L.R.and J.I.Ryu."Salmonella typhimurium LT2 strains which are r-m+ for all three chromosomally located systems of DNA restriction and modification."[J].J Bacteriol,1983,156(1):471-4.
[102]Raleigh,E.A.,J.Benner,et al.."Nomenclature relating to restriction of modified DNA in Escherichia coli."[J].J Bacteriol,1991,173(8):2707-9.
[103]王恒梁,冯尔玲,史兆兴,等.Red系统快速敲除痢疾杆菌asd基因[J].军事医学科学院刊,2002,26(3):161-164
[104]Datsenko K A,Wanner B L.One step inactivation of chromosomal genes in Escherichia coli K12 using PCR products[J].Proc Natl Acad Sci USA,2000,97(1):6640-6645
[105]Mulks,M.H.and J.M.Buysse."A targeted mutagenesis system for Actinobacillus pleuropneumoniae."[J].Gene,1995,165(1):61-6.